Trial intelligence / Profile preview

Mycophenolate for Pulmonary Sarcoidosis

NCT00262132Phase 3Terminated

Sponsor
Medical University of South Carolina
Start
Sep 2003
Primary completion
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mycophenolate mofetil in pulmonary sarcoidosis, sponsored by Medical University of South Carolina. Started Sep 2003; status: terminated.

02

Drugs

mycophenolate mofetil
03

Conditions

pulmonary sarcoidosis

Beyond the preview

Go deeper on NCT00262132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00262132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call